Les syndromes lipodystrophiques : des adipopathies congénitales ou acquises
Tài liệu tham khảo
Garg, 2004, Acquired and inherited lipodystrophies, N. Engl. J. Med., 18, 1220, 10.1056/NEJMra025261
Shimomura, 1998, Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy, Genes Dev., 15, 3182, 10.1101/gad.12.20.3182
Kim, 2000, Mechanism of insulin resistance in A-ZIP/F-1 fatless mice, J. Biol. Chem., 275, 8456, 10.1074/jbc.275.12.8456
Gavrilova, 2000, Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice, J. Clin. Invest., 105, 271, 10.1172/JCI7901
Yamauchi, 2002, Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, Nat. Med., 8, 1288, 10.1038/nm788
Magre, 2001, Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13, Nat. Genet., 28, 365, 10.1038/ng585
Windpassinger, 2004, Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome, Nat. Genet., 36, 271, 10.1038/ng1313
Agarwal, 2002, AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34, Nat. Genet., 31, 21, 10.1038/ng880
Magre, 2003, Prevalence of mutations in AGPAT2 among human lipodystrophies, Diabetes, 52, 1573, 10.2337/diabetes.52.6.1573
Andreelli, 2000, Normal reproductive function in leptin-deficient patients with lipoatropic diabetes, J. Clin. Endocrinol. Metab., 85, 715, 10.1210/jc.85.2.715
Oral, 2002, Leptin-replacement therapy for lipodystrophy, N. Engl. J. Med., 346, 570, 10.1056/NEJMoa012437
George, 2004, A family with severe insulin resistance and diabetes due to a mutation in AKT2, Science, 28, 1325, 10.1126/science.1096706
Vigouroux, 2000, Lamin A/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy, Diabetes, 49, 1958, 10.2337/diabetes.49.11.1958
Misteli, 2005, Genome instability in progeria: when repair gets old, Nat. Med., 11, 718, 10.1038/nm0705-718
Bonne, 1999, Mutations in the gene encoding lamin A/C cause autosomal dominant Émery–Dreyfuss muscular dystrophy, Nat. Genet., 21, 285, 10.1038/6799
Cao, 2000, Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy, Hum. Mol. Genet., 9, 109, 10.1093/hmg/9.1.109
Shackleton, 2000, LMNA, encoding lamin A/C, is mutated in partial lipodystrophy, Nat. Genet., 24, 153, 10.1038/72807
Vigouroux, 2005, Laminopathies: lipodystrophies, insulin resistance, syndromes of accelerated ageing... and others, Ann. Endocrinol., 66, 270, 10.1016/S0003-4266(05)81761-5
Caux, 2003, A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy, J. Clin. Endocrinol. Metab., 88, 1006, 10.1210/jc.2002-021506
Young, 2005, Type-A insulin resistance syndrome revealing a novel lamin A mutation, Diabetes, 54, 1873, 10.2337/diabetes.54.6.1873
Vigouroux, 2001, Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q/W mutations in the lamin A/C gene, J. Cell Sci., 114, 4459, 10.1242/jcs.114.24.4459
Lammerding, 2004, Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction, J. Clin. Invest., 113, 370, 10.1172/JCI200419670
Lloyd, 2002, A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies, Hum. Mol. Genet., 11, 769, 10.1093/hmg/11.7.769
De Sandre-Giovannoli, 2003, Lamin-A truncation in Hutchinson–Gilford progeria, Science, 300, 2055, 10.1126/science.1084125
Fong, 2004, Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice, Proc. Natl Acad. Sci. USA, 101, 18111, 10.1073/pnas.0408558102
Liu, 2005, Genomic instability in laminopathy-based premature aging, Nat. Med., 11, 780, 10.1038/nm1266
Varela, 2005, Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation, Nature, 437, 564, 10.1038/nature04019
Barroso, 1999, Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension, Nature, 402, 880, 10.1038/47254
Alberti, 2005, The metabolic syndrome – A new worldwide definition, Lancet, 366, 1059, 10.1016/S0140-6736(05)67402-8
Van Gaal, 2005, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study, Lancet, 365, 1389, 10.1016/S0140-6736(05)66374-X
Grinspoon, 2005, Cardiovascular risk and body-fat abnormalities in HIV-infected adults, N. Engl. J. Med., 352, 48, 10.1056/NEJMra041811
Jain, 2001, Metabolic complications associated with antiretroviral therapy, Antiviral Res., 51, 151, 10.1016/S0166-3542(01)00148-6
Gougeon, 2004, Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations, Antivir. Ther., 9, 161, 10.1177/135965350400900206
Nolan, 2004, Complications associated with NRTI therapy: update on clinical features and possible pathogenic mechanisms, Antivir. Ther., 9, 849, 10.1177/135965350400900609
Caron, 2004, HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro, AIDS, 18, 2127, 10.1097/00002030-200411050-00004
Lagathu, 2004, Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro, Antivir. Ther., 9, 911, 10.1177/135965350400900607
Dowell, 2000, Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors, J. Biol. Chem., 275, 41325, 10.1074/jbc.M006474200
Caron, 2001, The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance, Diabetes, 50, 1378, 10.2337/diabetes.50.6.1378
Caron, 2003, Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation, AIDS, 17, 2437, 10.1097/00002030-200311210-00005
Martin, 2004, Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study, AIDS, 18, 1029, 10.1097/00002030-200404300-00011
Domingo, 1999, Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy, AIDS, 13, 2261, 10.1097/00002030-199911120-00008
Nolan, 2003, Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy, AIDS, 17, 1329, 10.1097/00002030-200306130-00007
Jan, 2004, Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients, Antivir. Ther., 9, 555, 10.1177/135965350400900412
Stulnig, 2004, 11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes, Diabetologia, 47, 1, 10.1007/s00125-003-1284-4
Hegele, 2001, Premature atherosclerosis associated with monogenic insulin resistance, Circulation, 103, 2225, 10.1161/01.CIR.103.18.2225